Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
pembrolizumab
.
Show all posts
Showing posts with label
pembrolizumab
.
Show all posts
Wednesday, January 6, 2016
Lilly, Merck expand oncology clinical trial collaboration
›
Eli Lilly and Company (NYSE: LLY) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the exten...
›
Home
View web version